4.7 Article

Identification of a distinct population of CD133+CXCR4+ cancer stem cells in ovarian cancer

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

CD24+ ovary cancer cells exhibit an invasive mesenchymal phenotype

Kyu Sub Kang et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)

Article Oncology

Targeting CD133 in an in vivo ovarian cancer model reduces ovarian cancer progression

Amy P. N. Skubitz et al.

GYNECOLOGIC ONCOLOGY (2013)

Article Multidisciplinary Sciences

Ovarian surface epithelium at the junction area contains a cancer-prone stem cell niche

Andrea Flesken-Nikitin et al.

NATURE (2013)

Review Medicine, Research & Experimental

Small Molecule Inhibitors of CXCR4

Bikash Debnath et al.

THERANOSTICS (2013)

Article Cell Biology

Global Proteome Analysis of the NCI-60 Cell Line Panel

Amin Moghaddas Gholami et al.

CELL REPORTS (2013)

Article Oncology

Stem Cell Pathways Contribute to Clinical Chemoresistance in Ovarian Cancer

Adam D. Steg et al.

CLINICAL CANCER RESEARCH (2012)

Article Pathology

CD133 expression associated with poor prognosis in ovarian cancer

Jing Zhang et al.

MODERN PATHOLOGY (2012)

Article Multidisciplinary Sciences

CXCR4 Expression in Prostate Cancer Progenitor Cells

Anna Dubrovska et al.

PLOS ONE (2012)

Article Oncology

Stem Cell Quiescence

Ling Li et al.

CLINICAL CANCER RESEARCH (2011)

Review Cell & Tissue Engineering

Concise Review: Emerging Concepts in Clinical Targeting of Cancer Stem Cells

Zeshaan A. Rasheed et al.

STEM CELLS (2011)

Review Oncology

Rethinking ovarian cancer: recommendations for improving outcomes

Sebastian Vaughan et al.

NATURE REVIEWS CANCER (2011)

Article Oncology

Microenvironmental Regulation of Chemokine (C-X-C- Motif) Receptor 4 in Ovarian Carcinoma

Maria V. Barbolina et al.

MOLECULAR CANCER RESEARCH (2010)

Review Oncology

Cancer stem cells in solid tumors

Patrick C. Hermann et al.

SEMINARS IN CANCER BIOLOGY (2010)

Review Biotechnology & Applied Microbiology

Therapeutic implications of cancer a initiating cells

Alessandro Scopelliti et al.

EXPERT OPINION ON BIOLOGICAL THERAPY (2009)

Review Biotechnology & Applied Microbiology

Tumour-initiating cells: challenges and opportunities for anticancer drug discovery

Bin-Bing S. Zhou et al.

NATURE REVIEWS DRUG DISCOVERY (2009)

Article Multidisciplinary Sciences

Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment

Giulia Bertolini et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)

Review Oncology

Cancer stem cells in solid tumours: accumulating evidence and unresolved questions

Jane E. Visvader et al.

NATURE REVIEWS CANCER (2008)

Article Oncology

The NCI60 human tumour cell line anticancer drug screen

Robert H. Shoemaker

NATURE REVIEWS CANCER (2006)

Article Pathology

Isolation of renal progenitor cells from adult human kidney

B Bussolati et al.

AMERICAN JOURNAL OF PATHOLOGY (2005)

Article Medicine, Research & Experimental

CXCL12-CXCR4 interactions modulate prostate cancer cell migration, metalloproteinase expression and invasion

S Singh et al.

LABORATORY INVESTIGATION (2004)

Article Multidisciplinary Sciences

Identification of human brain tumour initiating cells

SK Singh et al.

NATURE (2004)

Article Cell & Tissue Engineering

CD133 (AC133) expression on AML cells and progenitors

SM Vercauteren et al.

CYTOTHERAPY (2001)

Article Multidisciplinary Sciences

Direct isolation of human central nervous system stem cells

N Uchida et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)

Article Genetics & Heredity

Systematic variation in gene expression patterns in human cancer cell lines

DT Ross et al.

NATURE GENETICS (2000)